Skip to content
Research Triangle Regional Partnership
  • Our Region
    • The Triangle
    • Our Counties
    • Talent
    • International
  • Do Business Here
    • Incentives & Grants
    • Investment
    • Startup Ecosystem
    • Featured Sites
  • Target Industries
    • Advanced Manufacturing
    • AgTech
    • CleanTech
      • EV & Battery Tech
    • Life Sciences
      • Gene & Cell Therapy
      • Bioeconomy
    • Technology
      • Cybersecurity
      • Defense Technology
      • Fintech
  • Newsroom
  • About Us
  • Events
  • Contact
  • Select Language
    • en_USEnglish
    • es_ESEspañol
    • fr_FRFrançais
    • de_DEDeutsch
    • it_ITItaliano
    • pl_PLPolski
    • sv_SESvenska
    • fiSuomi
    • da_DKDansk
    • he_ILעִבְרִית
    • zh_CNChinese
    • zh_TW繁體中文
    • ko_KR한국어
    • ja日本語

Gene Therapy

RTP gene therapy company Opus Genetics appoints CEO

Date Published: June 21, 2022
RESEARCH TRIANGLE PARK – The gene therapy company Opus Genetics has appointed its acting CEO Ben Yerxa, Ph.D., to a permanent role as…

Triangle gene therapy startup GeneVentiv Therapeutics awarded $250K loan from NC Biotech Center

Date Published: June 14, 2022
RALEIGH – GeneVentiv Therapeutics, a Triangle-area pre-clinical gene therapy company, has been awarded a $250,000 Strategic Research Loan (SRL) from…

Startup spotlight: Durham agtech firm could hold genetic key to better bananas & coffee

Date Published: February 14, 2022
Durham-based food technology startup Pairwise is going a little bit bananas…and coffee. The company – which uses its CRISPR-Cas9 gene editing know-how…

Targeting rare diseases: Inside Durham biotech startup’s latest deal

Date Published: January 13, 2022
Kriya Therapeutics is setting up a rare diseases unit in the Triangle with its latest acquisition. This week, the biotech…

Boost for NC gene therapy companies – a new rare disease consortium

Date Published: December 20, 2021
The nearly 30 million Americans who suffer from rare diseases have received some good news. The National Institutes of Health,…

Pfizer Invests $68.5 Million in New State-of-the-Art Facility in Durham, North Carolina to Further Advance Gene Therapy Capabilities

Date Published: December 15, 2021
Pfizer Inc. (NYSE: PFE) announced today the opening of a new, state-of-the-art clinical manufacturing facility in Durham, NC. The facility…

Durham gene therapy plant to help Pfizer develop treatments for rare diseases

Date Published: December 15, 2021
Drug giant Pfizer on Wednesday cut the ribbon on a new manufacturing facility in Durham that will focus on gene…

Ground breaking: Biogen’s $200M RTP gene therapy facility means new jobs

Date Published: November 18, 2021
Biogen will break ground today for a gene therapy manufacturing plant at its growing RTP campus. The company plans to…

Producing the newest medicines – and potentially cures: gene and cell therapies

Date Published: August 11, 2021
By Abbey Slattery Gene and cell therapies are paving the way to breakthrough treatments and potential cures for serious illnesses…

Contact Us

Send us an email to learn more about the Research Triangle Region.

Ryan Combs Executive Director, Research Triangle Regional Partnership Email rcombs@researchtriangle.org Email Research Triangle, North Carolina
A Special Thank You To Our Corporate Partners
Delta
Official Airline of the RTRP
Duke Energy
©2025 Research Triangle Regional Partnership
  • LinkedIn
  • YouTube
  • Accessibility
  • Privacy Policy
  • Sitemap